Skip to main content
. 2022 Aug 25;11(17):4979. doi: 10.3390/jcm11174979

Table 1.

Clinical characteristics of the patients.

Characteristics Value
Age, years 62.4 (21–78)
BMI, kg/m2 25.7 (16.4–36.4)
Sex, Women/Men 22/13
The cause of lymphedema
Complication of malignant tumor treatment 24 (68.6%)
Primary 6 (17.1%)
Cellulitis 5 (14.3%)
Duration of edema, m 52.5 (1–360)
≥1 past cellulitis episode(s) 11 (31.4%)
LEL index 272.4 (180.7–384.8)
Lymphoscintigraphy staging
I 7 (20%)
II 5 (14.3%)
III 3 (8.6%)
IV 12 (34.3%)
V 8 (22.9%)
ICG lymphography staging
I 8 (22.9%)
II 3 (8.6%)
III 14 (40%)
IV 4 (11.4%)
V 6 (17.1%)
NECST classification
0 3 (8.6%)
I 8 (22.9%)
II 8 (22.9%)
III 13 (37.1%)
IV 3 (8.6%)
The type of surgery
LVA 25 (71.4%)
LVA and VLT 5 (14.3%)
LVA and LS 2 (5.7%)
LVA, VLT and LS 3 (8.6%)

BMI, body mass index; LEL, lower extremity lymphedema; ICG, indocyanine green; NECST, normal, ectasis, contraction, and sclerosis type classification; LVA, lymphatic venous anastomosis; VLT, vascularized lymphatic channel transfer; LS, liposuction.